IndraLab

"Meanwhile, disopyramide was demonstrated to block I hERG1 at clinically relevant concentrations (IC 50 < 10 muM), and this action was proposed to constitute the molecular basis of its proarrhythmic effect."

21833176

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Disopyramide inhibits KCNH2. 5 / 5

INDRA sources:

Databases

Reading